FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2010/091/001054 [Registered on: 08/07/2010]
Last Modified On:
Post Graduate Thesis   
Type of Trial   
Type of Study    
Study Design  Single Arm Study 
Public Title of Study   A study of Condom catheter balloon to control excessive bleeding after childbirth. 
Scientific Title of Study   Evaluation of Uterine tamponade using condom catheter balloon in management of nontraumatic postpartum hemorrhage 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR Asmita Muthal Rathore 
Designation   
Affiliation   
Address  217, DG III
Vikaspuri
New Delhi
DELHI
110018
India 
Phone  011 28531848  
Fax    
Email  asmita.rathore@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  DR Asmita Muthal Rathore 
Designation   
Affiliation  Maulana Azad Medical College, New Delhi 
Address  217, DG III
Vikaspuri
New Delhi
DELHI
110018
India 
Phone  011 28531848  
Fax    
Email  asmita.rathore@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sonali Gupta 
Designation   
Affiliation   
Address  C-1/4A yamuna Vihar

New Delhi
DELHI
110054
India 
Phone  011 22914305  
Fax    
Email  sonali_2706@yahoo.co.in  
 
Source of Monetary or Material Support  
Department of obstetrics and gynecology, Maulana Azad Medical College, New Delhi 
 
Primary Sponsor  
Name  nil 
Address   
Type of Sponsor   
 
Details of Secondary Sponsor  
Name  Address 
nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr A M Rathore  Department of obstetrics and gynecology, Maulana Azad Medical College, NewDelhi  ,-

 
09968604345

asmita.rathore@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Maulana Azad Medical College, New Delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  postpartum hemorrhage,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  nil   
Intervention  uterine tamponade with condom catheter balloon  8-48 hours 
 
Inclusion Criteria  
Age From   
Age To   
Gender   
Details  Post partum hemorrhage not responding to medical management (appropriate doses of oxytocics and prostaglandins) 
 
ExclusionCriteria 
Details  1. Bleeding due to genital tract trauma and retained placental tissue 2. Known allergy to latex  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Time required to stop bleeding after tamponade is applied  control of hemorrhage 
 
Secondary Outcome  
Outcome  TimePoints 
Need for additional surgical measures eg devascularization ,B Lynch, hysterectomy  unstable hemodynamic status of mother 
 
Target Sample Size   Total Sample Size="15"
Sample Size from India="" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   Date Missing 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  12/10/2009 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)   
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   tamponade created at predefined point. Primary outcomes noted. If successful, tamponade continued for 8-48 hours with defined monitoring. Tamponade removed after criterias fulfilled. Secondary outcomes noted. 
Close